CXAI Q4 2025 Earnings EPS Misses Estimates Stock Declines 9 YUM Q1 2026 Earnings EPS Surges Past Estimates as Global Operations Drive Profitability CTOR Q1 2026 Earnings Significant EPS Miss Amid PreRevenue Stage RDW Q1 2026 Earnings EPS Misses Estimates Sharply Yet Stock Surges on Strategic Developments ATOS Q1 2026 Earnings EPS Surprise of 8223 Highlights Cost Management in ClinicalStage Biotech Compass Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Pipeline Progress